Literature DB >> 16447157

SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions.

Avram Z Traum1, Meghan P Wells, Manuel Aivado, Towia A Libermann, Marco F Ramoni, Asher D Schachter.   

Abstract

Proteomic profiling with SELDI-TOF MS has facilitated the discovery of disease-specific protein profiles. However, multicenter studies are often hindered by the logistics required for prompt deep-freezing of samples in liquid nitrogen or dry ice within the clinic setting prior to shipping. We report high concordance between MS profiles within sets of quadruplicate split urine and serum samples deep-frozen at 0, 2, 6, and 24 h after sample collection. Gage R&R results confirm that deep-freezing times are not a statistically significant source of SELDI-TOF MS variability for either blood or urine.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16447157      PMCID： PMC1447593          DOI： 10.1002/pmic.200500174

Source DB:  PubMed          Journal:  Proteomics        ISSN： 1615-9853            Impact factor:   3.984


  12 in total

1.  Characterization of renal allograft rejection by urinary proteomic analysis.

Authors:  William Clarke; Benjamin C Silverman; Zhen Zhang; Daniel W Chan; Andrew S Klein; Ernesto P Molmenti
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

2.  Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Authors:  Stefan Schaub; John Wilkins; Tracey Weiler; Kevin Sangster; David Rush; Peter Nickerson
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

3.  Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling.

Authors:  Manuel Aivado; Dimitrios Spentzos; Gil Alterovitz; Hasan H Otu; Franck Grall; Aristoteles A N Giagounidis; Meghan Wells; Je-Yoel Cho; Ulrich Germing; Akos Czibere; Wolf C Prall; Chris Porter; Marco F Ramoni; Towia A Libermann
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

4.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

5.  Bioinformatic analysis of the urine proteome of acute allograft rejection.

Authors:  Edmond O'Riordan; Tatyana N Orlova; Jianfeng Mei J; Khalid Butt; Praveen M Chander; Shafiq Rahman; Muong Mya; Rena Hu; Jahangir Momin; Elizabeth W Eng; Dierk J Hampel; Bertram Hartman; Matthias Kretzler; Veronica Delaney; Michael S Goligorsky
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

6.  Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons.

Authors:  Yonggwan Won; Ho-Jun Song; Taek Won Kang; Jung-Ja Kim; Byoung-Don Han; Seung-Won Lee
Journal:  Proteomics       Date:  2003-12       Impact factor: 3.984

7.  Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.

Authors:  David K Ornstein; Walter Rayford; Vincent A Fusaro; Thomas P Conrads; Sally J Ross; Ben A Hitt; Wesley W Wiggins; Timothy D Veenstra; Lance A Liotta; Emanuel F Petricoin
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

8.  A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.

Authors:  Yutaka Yasui; Margaret Pepe; Mary Lou Thompson; Bao-Ling Adam; George L Wright; Yinsheng Qu; John D Potter; Marcy Winget; Mark Thornquist; Ziding Feng
Journal:  Biostatistics       Date:  2003-07       Impact factor: 5.899

9.  Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.

Authors:  Piotr Lewczuk; Hermann Esselmann; Teja Wolfgang Groemer; Mirko Bibl; Juan Manuel Maler; Petra Steinacker; Markus Otto; Johannes Kornhuber; Jens Wiltfang
Journal:  Biol Psychiatry       Date:  2004-03-01       Impact factor: 13.382

10.  Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix.

Authors:  Y F Wong; T H Cheung; K W K Lo; V W Wang; C S Chan; T B Ng; T K H Chung; S C Mok
Journal:  Cancer Lett       Date:  2004-08-10       Impact factor: 8.679
View more
  12 in total

1.  Urine proteomics for profiling of human disease using high accuracy mass spectrometry.

Authors:  Alex Kentsis; Flavio Monigatti; Kevin Dorff; Fabien Campagne; Richard Bachur; Hanno Steen
Journal:  Proteomics Clin Appl       Date:  2009-09-01       Impact factor: 3.494

Review 2.  Application of proteomic analysis to the study of renal diseases.

Authors:  Matthew P Welberry Smith; Rosamonde E Banks; Steven L Wood; Andrew J P Lewington; Peter J Selby
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

3.  Urine proteomic profiling of pediatric nephrotic syndrome.

Authors:  Mona Khurana; Avram Z Traum; Manuel Aivado; Meghan P Wells; Manuel Guerrero; Franck Grall; Towia A Libermann; Asher D Schachter
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

Review 4.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

5.  Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

Authors:  Dale McLerran; William E Grizzle; Ziding Feng; William L Bigbee; Lionel L Banez; Lisa H Cazares; Daniel W Chan; Jose Diaz; Elzbieta Izbicka; Jacob Kagan; David E Malehorn; Gunjan Malik; Denise Oelschlager; Alan Partin; Timothy Randolph; Nicole Rosenzweig; Shiv Srivastava; Sudhir Srivastava; Ian M Thompson; Mark Thornquist; Dean Troyer; Yutaka Yasui; Zhen Zhang; Liu Zhu; O John Semmes
Journal:  Clin Chem       Date:  2007-11-02       Impact factor: 8.327

6.  Non-invasive markers of ureteropelvic junction obstruction.

Authors:  Stephane Decramer; Jean-Loup Bascands; Joost P Schanstra
Journal:  World J Urol       Date:  2007-08-14       Impact factor: 4.226

Review 7.  Biomarker analysis of stored blood products: emphasis on pre-analytical issues.

Authors:  Julien Delobel; Olivier Rubin; Michel Prudent; David Crettaz; Jean-Daniel Tissot; Niels Lion
Journal:  Int J Mol Sci       Date:  2010-11-17       Impact factor: 5.923

8.  Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry.

Authors:  Han Roelofsen; Gloria Alvarez-Llamas; Marianne Schepers; Karloes Landman; Roel J Vonk
Journal:  Proteome Sci       Date:  2007-01-15       Impact factor: 2.480

9.  Optimising storage conditions and processing of sheep urine for nitrogen cycle and gaseous emission measurements from urine patches.

Authors:  Alice F Charteris; Karina A Marsden; Jess R Evans; Harry A Barrat; Nadine Loick; Davey L Jones; David R Chadwick; Laura M Cárdenas
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

10.  A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.

Authors:  K Benkali; P Marquet; Jp Rérolle; Y Le Meur; Ln Gastinel
Journal:  BMC Genomics       Date:  2008-11-14       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.